Key takeaways:
Neuroendocrine tumors are rare cancers that come from neuroendocrine cells that release hormones.
These tumors can occur anywhere in the body, but they’re most common in the gastrointestinal tract and lungs.
Most neuroendocrine tumors are highly treatable.
Neuroendocrine tumors (NETs) are a rare type of tumor. Only about 12,000 people in the U.S. are diagnosed with NETs per year. There are many different types of NETs, and they can occur anywhere in the body. These tumors equally affect men and women. But they grow slowly and are very treatable.
In this article, we discuss the details of NETs, from causes and symptoms to diagnosis and treatment.
What are neuroendocrine cells?
To understand NETs, you first need to understand a bit about the cells they come from: neuroendocrine cells. “Neuro” means nerves, and “endocrine” means hormones. So neuroendocrine cells are special cells that respond to signals from nerves by releasing hormones.
Neuroendocrine cells are found all over the body, such as in the:
Stomach and bowels (gastrointestinal, or GI, tract)
Lungs
Pancreas
Pituitary gland (brain)
Adrenal glands
Thyroid and parathyroid glands in the neck
Kidneys and bladder
Genital organs (like the ovaries and prostate)
Skin
What causes neuroendocrine tumors?
NETs happen when a neuroendocrine cell becomes cancerous. Cancerous cells result from changes (mutations) in DNA that cause them to reproduce rapidly. The more copies a cancerous cell makes of itself, the bigger the tumor.
Some NETs are hereditary — meaning they’re related to genetic conditions that cause tumors. An example of a hereditary NET is multiple endocrine neoplasia type 1 (MEN1). But most NETs are sporadic — meaning they happen out of nowhere.
How are neuroendocrine tumors different from other tumors?
NETs differ from other tumors in two ways:
Location: Neuroendocrine cells exist all over the body, and so do NETs. This makes them different from other tumors, which start in specific organs. For example, breast cancer starts in the breast. But NETs can start anywhere. The most common locations include the GI tract (65% of cases) and lungs (25%).
Release of hormones: Some NETs are “functional” — meaning they release more hormones than they should. This excess of hormones leads to NETs having specific symptoms that other tumors don’t have (more on this below).
Types of neuroendocrine tumors: Learn which parts of the body are most likely to be affected by these tumors.
How serious are neuroendocrine tumors? Learn about the survival rates for different types of neuroendocrine tumors.
What’s Zollinger-Ellison syndrome? Read about this rare type of neuroendocrine tumor that causes heartburn, ulcers, abdominal pain, and diarrhea.
What are the different types of NETs?
Neuroendocrine tumors can start in many different parts of the body. Here are some of the most common types:
NETs of the GI tract, lungs, or pancreas
Pheochromocytomas (typically found in the adrenal gland)
Paragangliomas (in the head, neck or torso)
Pituitary NET
Medullary thyroid cancer
NETs of the reproductive system
Merkel cell carcinoma (develops in areas of skin highly exposed to the sun)
What are the symptoms of a neuroendocrine tumor?
Since there are so many different kinds of neuroendocrine tumors, symptoms vary. Every person has their own unique combination of symptoms, and some people may not have symptoms at all.
Symptoms fall into three main categories.
1. General cancer symptoms
The symptoms of an NET are similar to those of general cancer, such as:
Weight loss
Lack of appetite
Fatigue
2. Symptoms related to tumor location
Other symptoms can depend on where the NET is located, such as:
Pain in the affected location
A red, brown, or purple lump or growth on the skin
Shortness of breath, cough, or coughing up blood (tumors in the lung)
Diarrhea, constipation, or bloody stools (tumors in the GI tract)
3. Symptoms related to the release of hormones
As we said above, NETs have different symptoms than other tumors due to the excess hormones that they release. Here are some of these symptoms:
Abdominal pain, stomach ulcers, and diarrhea — when NETs release too much stomach acid
Low blood sugar — when NETs release too much insulin
Flushing of the face, wheezing, rapid heartbeat, and diarrhea (carcinoid syndrome)
How do you diagnose a neuroendocrine tumor?
NETs can be harder to diagnose than other types of tumors since there are so many different kinds of them. NETs that release hormones tend to be diagnosed earlier. That’s because the symptoms of too much hormone prompt people to seek medical care sooner.
To diagnose a NET, a healthcare professional might order any of these tests:
CT or MRI imaging
Endoscopy, which involves inserting a camera into the stomach or rectum to examine the inside of the stomach or bowels
Special imaging, which involves injecting a radioactive substance into a vein to locate tumor cells (like octreotide scans)
Blood or urine tests to check hormone levels (tumor markers)
NETs can be diagnosed by a primary care provider or in the emergency room (ER). Once testing confirms a cancer diagnosis, an oncologist (cancer specialist) will take the lead when it comes to treatment.
How do you treat a neuroendocrine tumor?
Most neuroendocrine tumors are very treatable. Treatment depends on a couple of different factors, like:
Type of neuroendocrine cell causing the NET and whether it makes hormones
Location of the NET
Any metastasis (spread) of the NET and how quickly the NET is growing or spreading
Here are some of the treatment options that can be used to treat NETs:
Surgery to remove the tumor if it hasn’t spread yet
Chemotherapy medications
Targeted therapy (medications that target specific parts of cancer cells)
Medications to manage symptoms (like diarrhea)
Keep in mind, some people may need a combination of different therapies. And it’s important to note that a solid support system and tools to help cope with a cancer diagnosis and treatment are really important too.
Frequently asked questions
Yes. Some types of NETs are benign (non-cancerous). These tend to grow slowly and don’t spread to other parts of the body.
The seriousness of a pancreatic NET depends on what type of tumor it is, since some are benign and others are cancerous. For example, an insulinoma (a tumor that makes the insulin hormone) is a common benign type of pancreatic NET that’s usually cured with surgery.
No, they aren’t the same thing. There are many different types of NET. A carcinoid tumor is just one example of a common type of NET.
Yes. Some types of NETs are benign (non-cancerous). These tend to grow slowly and don’t spread to other parts of the body.
The seriousness of a pancreatic NET depends on what type of tumor it is, since some are benign and others are cancerous. For example, an insulinoma (a tumor that makes the insulin hormone) is a common benign type of pancreatic NET that’s usually cured with surgery.
No, they aren’t the same thing. There are many different types of NET. A carcinoid tumor is just one example of a common type of NET.
The bottom line
NETs are a rare and varied type of cancer that cause a range of symptoms. They’re different from other tumor types, but cancer of any kind is scary. The good news is most NETs are treatable, and new therapies are arriving every year. Together with a healthcare professional and a support system, you can find a way through this.
Why trust our experts?



References
American Cancer Society. (2025). Targeted drug therapy for pancreatic neuroendocrine tumors (pNET). American Society of Clinical Oncology.
Cancer Support Community. (n.d.). Neuroendocrine & carcinoid tumors.
Demarco, C. (2024). 10 things to know about neuroendocrine tumors. The University of Texas MD Anderson Cancer Center.
Gut, P., et al. (2015). Familial syndromes associated with neuroendocrine tumors. Contemporary Oncology.
Healy, M. (2023). Octreotide scan. OncoLink.
Ludgate, M. (2014). Merkel cell carcinoma. DermNet.
MedlinePlus. (2024). Carcinoid syndrome.
MedlinePlus. (2024). Pancreatic neuroendocrine tumors.
National Cancer Institute. (2022). Pancreatic neuroendocrine tumors (islet cell tumors)treatment (PDQ)–patient version. National Institutes of Health.
National Cancer Institute. (2023). Tumor markers. National Institutes of Health.
National Organization for Rare Diseases. (2023). Multiple endocrine neoplasia type 1.
NHS Inform. (2024). Neuroendocrine tumours.
Sultana, Q., et al. (2023). A comprehensive review on neuroendocrine neoplasms: Presentation, pathophysiology and management. Journal of Clinical Medicine.
Taal, B. G., et al. (2004). Epidemiology of neuroendocrine tumors. Neuroendocrinology.
Tsoli, M., et al. (2018). Current best practice in the management of neuroendocrine tumors. Therapeutic Advances in Endocrinology and Metabolism.










